期刊文献+

白内障术后眼内炎的危险因素及临床分析 被引量:21

Risk Factor and Clinical Analysis of Endophthalmitis after Cataract Surgery
下载PDF
导出
摘要 目的探讨白内障术后眼内炎的危险因素和临床表现及玻璃体切割术治疗术后眼内炎的预后。方法收集白内障术后6周内发生眼内炎并于我院行玻璃体切割术的患者25例。将全部患者依据白内障术前既往史中危险因素的有无,分为伴有危险因素组(A组)和不伴有危险因素组(B组),回顾性分析两组的临床表现及预后。结果两组的病原菌检出率分别为A组60%,B组66%。最终视力1.0以上的比例两组分别为10%和46%,A组显著低于B组(P<0.05)。A组的病原菌以耐甲氧西林金黄色葡萄球菌、溶血性链球菌和肠球菌居多。两组均有约70%的角膜切口出现术后切口闭合不全,且未被结膜覆盖的切口在A组中显著增多(P<0.05)。结论伴有危险因素的白内障术后眼内炎患者的视力预后不良,对此类患者行白内障手术时必须谨慎选择并制作切口。 Objective To study the risk factors and clinical features of endophthalmitis after cataract surgery,and to discuss the visual prognosis after vitrectomy for endophthalmitis. Methods This study was made on 25 eyes that underwent a vitrectomy for endophthalmitis which had developed within 6 weeks after cataract surgery. They were divided into 2 groups according to the presence (group A) or absence (group B) of risk factors, and the clinical features and prognosis were retrospectively compared. Results The culture-positive rate in group A and B was 60% and 66% ,respectively. The incidence of a final visual acuity of more than 1.0 was significantly lower in group A ( 10% ) than in group B (46%,P 〈 0.05). Methicilhn-resistant staphylococcus aureus,hemolytic streptococcus and enterococcus were frequently de- tected in group A. Leakage from the cataract wound was found in about 70% of the patients with corneal incisions, and a wound that had not been covered by the conjunctiva was significantly more frequent in group A (P 〈 0.05). Conclusion Postoperative endophthalmitis has a worse visual prognosis in patients with risk factors, so precise wound construction during cataract surgery is necessary in these patients.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2013年第4期301-303,共3页 Journal of China Medical University
基金 国家自然科学基金资助项目(81000402)
关键词 术后眼内炎 玻璃体切割术 危险因素 白内障 postoperative endophthalmitis vitrectomy risk factor cataract
  • 相关文献

参考文献11

  • 1姚克,章征.白内障术后眼内感染及其防治[J].眼科,2005,14(1):6-8. 被引量:47
  • 2Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis fol- lowing cataract surgery, a systematic review of the literature [J]. Arch Ophthalmol, 2005,123 (5) : 613-620.
  • 3Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery [J ]. Can J Ophthalmol, 2000,35 (7) : 373-378.
  • 4Li J, Morlet N,Ng JQ, et al. Significant nonsurgical risk factors for endophthalmitis after cataract surgery: EPSWA fourth report [ J ]. In- vest Ophthalmol Vis Sci, 2004,45 (5) : 1321-1328.
  • 5Phillips WB 2nd,Tasman WS. Postoperative endophthalmitis in as- sociation with diabetes mellitus [J]. Ophthalmology, 1994, 101 (3): 508-518.
  • 6Nakata K, Inoue Y, Harada J, et al. A high incidence of Staphylococ- cus aureus colonization in the external eyes of patients with atopic dermatitis [ J ]. Ophthalmology, 2000,107 ( 12 ) : 2167-2171.
  • 7Daft BH, Wisniewski SR, Kelsey SF, et al. Diabetes and postoperative endophthalmitisintheendophthalmitis vitrectomy study[J].ArchOph- thalmol, 2001,119 (5) : 650-656.
  • 8Endophthalmitis Vitrectomy Study Group. Results of the endoph- thalmitis vitrectomy study. A randomized trial of immediate vitrecto- my and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis [J]. Arch Ophthalmol, 1995,113 (12): 1479 - 1496.
  • 9Cooper BA,ltolekamp NM,Bohigian G,et al. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds [ J ]. Am J Ophthalmol, 2003,136 (2) : 300-305.
  • 10Endophthalmitis Study Group, European Society of Cataract & Re- fractive Surgeons. Prophylaxis of postoperative endophthalmitis fol- lowing cataract surgery:results of the ESCRS multicenter study and identification of risk factors [J ]. J Cataract Refract Surg,2007,33 (6) : 978-988.

二级参考文献20

  • 1Powe NR,et al. Arch Ophthalmol,1994,112:239-252.
  • 2Javitt JC,et al. Arch Ophthalmol,1991,109:1085-1089.
  • 3Ormerod LD,et al. Ophthalmology, 1993,100:715-723.
  • 4Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol, 1995,113:1479-1496.
  • 5Starr MB. Surv Ophthalmol, 1983,27:353-373.
  • 6Colleaux KM,et al.Can J Ophthalmol,2000,35:373-378.
  • 7Hodge WG,et al. Invest Ophthalmol Vis Sci, 1995,36:S155.
  • 8Huang DG. Ocluar fluoroquinolones resistance incidence,etiology,and role of new fluoroquinolones. 18th congress of the Aiss-Pacific Academy of Ophthalmology. March 13,2001, Taipei, Taiwan.
  • 9Speaker MG, et al. Ophthalmology, 1991, 98: 1769-1775.
  • 10Apt L,et al. Am J Ophthalmol,1995,119:701-705.

共引文献46

同被引文献134

引证文献21

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部